Mayne Pharma Group Ltd has released a press release.
Clarification statement
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
In the deck
Earlier from Mayne Pharma
- Mayne Pharma acquires rights to generic Duragesic in the US
- License and supply agreement for generic Nuvaring in the US
- 2017 Half Year Media Release
- Mayne Pharma launches Butalbital / APAP tablets in the US
- Mayne Pharma launches Amiodarone 100mg tablets
Later from Mayne Pharma
- FDA approval and first generic launch of Acticlate tablets
- Mayne Pharma adds two products to its Australian portfolio
- Mayne Pharma launches clozapine tablets in the US
- 2017 CEOs Speech
- 2018 Half Year Media Release
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma